Atlas Trials

A Prospective Control Study of Cidan Capsule Combined With TACE in Hepatocellular Carcinoma

Clinical trial NCT02253511 · UNKNOWN

Trial details

NCT number
NCT02253511
Sponsor
Zheng Donghai
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2014-07-01
Primary completion
2017-07-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.